Premium
REAL WORLD OUTCOMES OF OBINUTUZUMAB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Author(s) -
Hughes M.E.,
Suen C.,
Namoglu E.,
Schuster S.J.,
Svoboda J.,
Landsburg D.J.,
Rhodes J.,
Loren A.,
Stadtmauer E.,
Nasta S.D.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.48_2631
Subject(s) - medicine , obinutuzumab , chlorambucil , rituximab , discontinuation , chronic lymphocytic leukemia , oncology , regimen , bendamustine , salvage therapy , refractory (planetary science) , progression free survival , surgery , chemotherapy , lymphoma , leukemia , cyclophosphamide , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom